Label: MEDIRELIEF- lidocaine patch

  • NDC Code(s): 73486-102-25
  • Packager: FARLA MEDICAL HEALTHCARE LTD
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated February 23, 2024

If you are a consumer or patient please visit this version.

  • Drug Facts

    Active Ingredients & Purpose

    Active ingredients (in each patch) Purpose

    Lidocaine 4%..............................................................................................Topical analgesic

  • Uses

    For the temporary relief of pain.

  • Warnings

    FOR EXTERNAL USE ONLY. Avoid contact with the eyes.

    Do not use

    • in large quantities, particularly over raw surfaces or blistered areas
    • on sensitive skin
    • if allergic to any ingredients in this product

    Stop use and ask a doctor if

    • condition worsens
    • redness is present
    • symptoms persist for more than 7 days or clear up and occur again within a few days

    If pregnant of breast-feeding

    ask a health professional before use.

    KEEP OUT OF REACH OF CHILDREN

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • adults & children 12 years of age and older: apply to affected area not more than 3 to 4 times daily

    - clean dry affected area

    - remove film from patch and apply to skin (see illustration)

    • children under 12 years of age: consult a doctor

  • Other Information

    • store at room temperature 68-77°F (20-25°C)
    • do not store in direct sunlight or expose to excessive heat and moisture

    TAMPER EVIDENT: Do not use if pouch containing the patch is torn or broken.

  • Inactive Ingredients

    dihydroxyaluminum aminoacetate, glycerin, kaolin, methylparaben, polyacrylic acid, polysorbate 80, povidones, propylene glycol, propylparaben, sodium polyacrylate, tartaric acid, titanium dioxide, water

  • Principal Display Panel

    NDC: 73486-102-25
    Count: (3.9”x5.5”) 5 Patches Box

  • INGREDIENTS AND APPEARANCE
    MEDIRELIEF 
    lidocaine patch
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:73486-102
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    LIDOCAINE (UNII: 98PI200987) (LIDOCAINE - UNII:98PI200987) LIDOCAINE4 g
    Inactive Ingredients
    Ingredient NameStrength
    PROPYLPARABEN (UNII: Z8IX2SC1OH)  
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3)  
    WATER (UNII: 059QF0KO0R)  
    DIHYDROXYALUMINUM AMINOACETATE ANHYDROUS (UNII: 1K713C615K)  
    POVIDONE (UNII: FZ989GH94E)  
    METHYLPARABEN (UNII: A2I8C7HI9T)  
    KAOLIN (UNII: 24H4NWX5CO)  
    POLYSORBATE 80 (UNII: 6OZP39ZG8H)  
    POLYACRYLIC ACID (250000 MW) (UNII: 9G2MAD7J6W)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    TARTARIC ACID (UNII: W4888I119H)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    SODIUM POLYACRYLATE (8000 MW) (UNII: 285CYO341L)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:73486-102-255 in 1 CARTON05/26/2020
    11 in 1 POUCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM01705/26/2020
    Labeler - FARLA MEDICAL HEALTHCARE LTD (230061759)